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Abstract
Background Recently, the laparoscopic sleeve gastrectomy
(LSG) has become popular as a single-stage procedure for
the treatment of morbid obesity and its co-morbidities.
However, the incidence of micronutrient deficiencies after
LSG have hardly been researched.
Methods From January 2005 to October 2008, 60 patients
underwent LSG. All patients were instructed to take daily
vitamin supplements. Patients were tested for micronutrient
deficiencies 6 and 12 months after surgery.
Results Anemia was diagnosed in 14 (26%) patients. Iron,
folic acid, and vitamin B12 deficiency was found in 23
(43%), eight (15%), and five (9%) patients, respectively.
Vitamin D and albumin deficiency was diagnosed in 21
(39%) and eight (15%) patients. Hypervitaminosis A, B1,
and B6 were diagnosed in 26 (48%), 17 (31%), and 13
(30%) patients, respectively.
Conclusions Due to inadequate intake and uptake of
micronutrients, patients who underwent LSG are at serious
risk for developing micronutrient deficiencies. Moreover,
some vitamins seem to increase to chronic elevated levels
with possible complications in the long-term. Multivitamins
and calcium tablets should be regarded only as a minimum
and supplements especially for iron, vitamin B12, vitamin
D, and calcium should be added to this regimen based on
regular blood testing.
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Introduction
A laparoscopic sleeve gastrectomy (LSG) is often used as a
first-stage procedure followed either by Laparoscopic
Roux-en-Y gastric bypass (LRYGB) or duodenal switch
(DS). LSG is performed to obtain weight loss and co-
morbidity reduction by restricting the food capacity of the
stomach. Currently, LSG is performed less often than
laparoscopic gastric banding and LRYGB, but reports of
LSG used as a single procedure in morbidly obese patients
are increasing [1–8].
Deficiencies in micronutrients after bariatric procedures
are a known threat if not corrected appropriately [9–13].
Surprisingly, reports on anemia and micronutrient deficien-
cies specifically in patients who underwent LSG are scarce.
As part of our standard follow-up care, we conducted this
prospective study to evaluate the deficiencies in the first
year following LSG.
Patients and Methods
From January 2005 to October 2008, 60 morbidly obese
patients were treated with an LSG by two surgeons as a
first-stage procedure towards a DS. This group of patients
consisted of 36 males and 24 females with a mean age of 44
(18–70) years. Mean initial weight and body mass index
(BMI) were 178 (±33.9) kg and 56.8 (±10.9) kg/m
2,
respectively. Demographics are shown in Table 1.
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reduce operative risks (ASA score) of the DS in the second
stage. In our clinic, the gastric volume is reduced by
stapling the gastric fundus and greater curvature parallel to
a 36 French boogie, which is inserted in the stomach
through the esophagus. Stapling starts from a distance of 3
to 5 cm from the pylorus at the greater curvature side
towards the angle of His. This results in a tube-like stomach
made from the lesser curvature only.
Standard laboratory evaluation was performed preopera-
tively consisting of a complete blood count, a mean cell
volume (MCV) and kidney function. Results are shown in
Table 2. After 6 and 12 months, the laboratory evaluation
was repeated along with plasma iron, total iron binding
capacity (TIBC), calcium, serum calcidiol (vitamin D3),
parathyroid (PTH), serum retinol (vitamin A), serum thiamin
(vitamin B1), serum pyridoxine (vitamin B6), serum folate
(vitamin B11), and serum cobalamin (vitamin B12).
Patients were instructed to take multivitamin tablets
three times daily (150% RDA). Other postoperative
medication consisted of a CaD 1000/880® sachet for 1 year
to prevent bone loss, Omeprazol® 40 mg once daily for
6 months to prevent ulceration of the staple lines and the
remaining stomach and 5700U of Fraxiparine® once daily
for 6 weeks postoperatively to prevent thrombosis.
During the first year of follow-up, six patients, none of
which were anemic before surgery, underwent a DS as the
second stage for the treatment for their morbid obesity. These
patients wereexcluded for the 12-month laboratoryevaluation.
Laboratory results were evaluated according to the
values mentioned in Table 3. Once a deficiency was
identified, it was treated accordingly. Data were prospec-
tively collected and processed using SPSS16®. All data are
reported as mean ± standard error of the mean unless
otherwise specified. P<0.05 was considered significant.
Results
Preoperatively, five (8.3%) patients were anemic of which one
had microcytic red blood cells. Additionally, two patients with-
out anemia were diagnosed with microcytic red blood cells.
Perioperative complications occurred in two patients.
One patient had a staple line leakage that was oversewn
during reoperation. A second patient developed a leakage in
the staple line at the esophageal–gastric junction which was
clipped endoscopically and resolved after a few months.
One year after surgery mean weight loss and excess BMI
loss were 51 kg and 16.4 kg/m
2, respectively. Mean excess
weight loss was 52% (22.1–84.3%) after the first year. All
patients adhered to the multivitamin supplements advised in
the first year. Laboratory results are shown in Table 3.
Anemia de novo developed in ten patients during the
first year. Only one patient who was anemic before surgery
reached a normal Hb level with suppletion of the
deficiencies found. From all new anemic patients, only
two developed microcytic red blood cells. In total, 14
(26%) patients where anemic after 1 year.
Iron deficiency was found in 23 (43%) patients. From
these patients, only three were diagnosed with a raised
TIBC and six developed microcytic red blood cells.
Calcium levels corrected for albumin remained between
acceptable levels. Two patients had slightly raised levels,
with a maximum of 2.58 mmol/L. Of more concern were
the high PTH levels and low levels of vitamin D found.
Twenty-one (39%) patients had elevated PTH levels, and
21 (39%) patients were diagnosed with low serum vitamin
D levels. This shows a fast change in bone metabolism after
LSG, despite the specific medication that was prescribed
for preventing bone loss.
In a number of patients, vitamin levels were above
normal range. Vitamin A appeared to be high in 26 (48%)
patients, vitamin B1 was high in 17 (31%) patients, and
vitamin B6 was high in 13 (30%) patients. Vitamin B1,
however, was also low in six (11%) patients.
Folicaciddeficiencywasfoundineight(15%)patientsand
vitamin B12 deficiency in five (9%) patients. No patients
developed macrocytic red blood cells during the first year.
Discussion
Deficiencies in micronutrients in morbidly obese patients
are frequently diagnosed. Due to a limited diet for certain
Table 2 Preoperative laboratory outcomes
Level Number of patients (%)
Hb Low 5 (8.3%) of which 1 was microcytic
Normal 55 (91.7%) of which 2 were microcytic
MCV Microcytic 3 (5.0%)
Normocytic 57 (95.0%)
Macrocytic 0 (0%)
Table 1 Demographics
Parameter Values (Standard deviation)
Number of patients 60
Male 34 (56.6%)
Female 26 (43.3%)
Age 43.6 (18–70)
Initial weight, kg 178.4 (±33.9)
Initial BMI, kg/m
2 56.8 (±10.9)
208 OBES SURG (2011) 21:207–211micronutrients, a great number of patients already develop
these deficiencies prior to a bariatric procedure [14, 15].
Because LSG is a restrictive procedure and therefore lacks
the malabsorptive component of for example a RYGB, the
risk for developing deficiencies after surgery is considered
low and therefore often not tested. However, because of the
resection of the fundus, a number of micronutrients like
iron and vitamin B12 are less likely to be absorbed, and the
low risk status for developing deficiencies can be ques-
tioned [11, 16–18].
In the past, a number of publications presented data on
micronutrient deficiencies found after partial gastrectomy
for the treatment for ulcer disease. Iron, folate, and vitamin
B12 deficiencies were most frequently reported. Long-term
follow-up was advised to identify anemia, vitamin, and
mineral deficiencies [19–23].
During the first year of follow-up, we found that anemia
was identified in almost a third of patients. This implicates
that preventing and screening for anemia and possible
deficiencies leading to anemia should be one of the
priorities in postoperative care. Although only eight
patients developed abnormal MCVs it is likely that, with
23 (43%) patients developing iron deficiency and eight
(15%) patients developing folate deficiency, these two
deficiencies eventually contribute to the number of anemic
patients. The iron deficiencies found can be partially
explained by pre-existing shortage [14], but also by the
LSG itself. Iron needs to be transformed to an absorbable
form by hydrochloric acid in the normal stomach [11, 14].
The quantity of hydrochloric acid produced in the stomach
is reduced and nutrients may pass the stomach faster after
an LSG, thus making it more difficult to absorb iron [5].
Folic acid stores deplete quickly when intake is insufficient.
This is also the most likely explanation for the eight
patients (15%) who were found to have folate deficiency
[24]. A normal individual has an average store of 2 mg of
vitamin B12 that should last for 2 years when intake is
insufficient. Morbidly obese patients have a higher risk of
having a pre-existing vitamin B12 deficiency or lower
storage levels, due to insufficient intake. Vitamin B12
uptake after LSG can become inadequate due to the lower
production of hydrochloric acid which is needed to release
bounded vitamin B12 in food [16, 17]. In the first year, five
patients were diagnosed with a vitamin B12 deficiency, but
it can be expected that this number will increase over the
years when vitamin B12 stores have depleted.
Normal values Mean value (±SD) Total (%)
Hb Male >8.4 mmol/L 8.5 mmol (±0,9) Anemia 14/54 (26%)
Female >7.4 mmol/L
MCV 80–100 fL 87 fL (±6) Micro 8/54 (15%)
Macro 0/54 (0%)
Iron 9–31 μmol/L 13.2 μmol/L (±5,6) Low 23/54 (43%)
High 0/54 (0%)
TIBC 45–81 nmol/L 58 nmol/L (±14) Low 0/54 (0%)
High 3/54 (6%)
Calcium 2.10–255 mmol/L 2.34 mmol/L (±0.10) Low 0/54 (0%)
High 2/54 (4%)
PTH 1.3–6.8pmol/L 5.7pmol/L (±3.0) Low 0/54 (0%)
High 21/54(39%)
Albumin 35–50 G/L 38,7 G/L (±4,0) Low 8/54(15%)
High 0/54(0%)
Vitamin A 1.05–2.80 μmol/L 2.59 μmol/L (±0.9) Low 2/54 (4%)
High 26/54 (48%)
Vitamin B1 95–175 nmol/L 153 nmol/L (±41) Low 6/54 (11%)
High 17/54 (31%)
Vitamin B6 25–100 nmol/L 115 nmol/L (±129) Low 0/44 (0%)
High 13/44 (30%)
Folic acid 9–36 nmol/L 178.0 nmol/L (±9.4) Low 8/54 (15%)
High 2/54 (4%)
Vitamin B12 150–640pmol/L 296pmol/L (±106) Low 5/54 (9%)
High 1/54 (2%)
Vitamin D 30–100 nmol/L 47 nmol/L (±23) Low 21/54(39%)
High 0/54 (0%)
Table 3 Postoperative laborato-
ry outcomes
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LSG. Part of this change is explained by the weight loss
itself due to the loss of pressure on the weight bearing
bones, thus losing a potent stimulant for bone preservation.
Furthermore, normal levels of vitamin D are essential for an
adequate intestinal calcium uptake. A shortage in vitamin D
eventually leads to a negative calcium balance and causes a
compensatory rise in PTH to promote bone resorption [25,
26]. Although calcium levels were almost all within
acceptable margins, 39% of the patients were diagnosed
with elevated PTH levels and 39% were diagnosed with
vitamin D deficiency. Suboptimal vitamin D levels
(<50 nmol/L) occurred in 30 (55.5%) patients. The rise in
PTH is, in some cases, most likely due to secondary
hyperparathyroidism and not solely explained by a de-
creased uptake of calcium by insufficient calcium intake or
low vitamin D levels. Albumin levels dropped in the first
year resulting from protein malnutrition especially in the
first months after the LSG. This is a second explanation for
these results. Clearly, these patients are at risk for
osteoporosis in the long-term when not corrected or treated
for their calcium, vitamin D, and albumin deficiencies.
Another phenomenon arises when patients who under-
went LSG are supplemented with multivitamins. Some
vitamins showed a significant rise in serum levels. Serum
vitamin A was elevated most frequently (48%). It is known
for its function in cell differentiation and phototransduction.
An excess in serum vitamin A can lead to ataxia, alopecia,
dry skin, hepatotoxia, hepatomegaly, and might have an
effect on bone metabolism by increasing bone resorption
[27, 28]. Furthermore, high serum levels of vitamin A can
be harmful in pregnant women due to the teratogenic
effects on the fetus [13, 29, 30]. The serum levels in our
patients, however, did not exceed 4 μmol/L after 1 year.
Vitamin B1 was low in six (11%) patients, but was found
t o oh i g hi n1 7( 3 1 % )p a t i e n t sw i t ham a x i m u mo f
230 nmol/L. Neurological abnormalities like Wernicke–
Korsakoff can occur when thiamin levels are below the
adequate level [11]. There has even been a report on
Wernicke's encephalopathy after an LSG [31]. Reports on
anaphylactic shock after intake of high doses of vitamin B1
have been published, but complications due to high levels
seem rare [32, 33].
As vitamin B6 plays a role in amino acid metabolism,
gluconeogenesis, and neurotransmitter synthesis, it is impor-
tant to ensure adequate serum levels [32]. No patients had
deficient serum vitamin B6, which is less than after a RYGB
[34]. During this study, one patient developed neuropathy in
hands and feet, which can be a symptom of high levels of
vitamin B6 [35]. This patient had taken extra vitamin B6 on
his own initiative, and serum levels had risen to seven times
the maximum normal serum level. Supplements were
stopped, and the symptoms vanished after a few weeks.
Conclusion
Supplementing patients is a very important part of patient
care after every bariatric procedure. Balancing between low
and high levels of micronutrients is a challenging part of
postoperative care. In this study, a quarter of our patients
were diagnosed with anemia, over 40% with iron deficien-
cy and almost 40% with secondary hyperparathyroidism in
the first year postoperative. We want to stress the risk of
developing certain deficiencies after LSG, but also the risk
of developing undesirable high levels of micronutrients.
Our concern is that, due to the use of multivitamin tablets
after LSG in the long-term, the serum levels of some
potential harmful vitamins will be chronically elevated or
rise towards toxic levels. The multivitamin and CaD
regiment used in this study is insufficient for supplementing
patients after LSG. We therefore advise to prescribe
multivitamins and calcium tablets only as a minimum and
to withdraw or add supplements to this regimen based on
regular blood testing, especially for iron, vitamin B12,
vitamin D, and calcium.
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